Schroder Investment Management Group Argenx Se Transaction History

Schroder Investment Management Group

$122 Billion
Q3 2025

A detailed history of Schroder Investment Management Group transactions in Argenx Se stock. As of the latest transaction made, Schroder Investment Management Group holds 16,460 shares of ARGX stock, worth $14.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,460

Previous 23,628 30.34%

Holding current value

$14.9 Million

Previous $13 Million 6.79%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$538.64 - $768.0 $3.86 Million - $5.51 Million	-7,168 Reduced 30.34%	16,460 $12.1 Million
Q2 2025 Aug 13, 2025	BUY	$532.27 - $656.65 $12.6 Million - $15.5 Million	23,628 New	23,628 $13 Million
Q1 2024 May 14, 2024	SELL	$356.95 - $413.29 $2.23 Million - $2.58 Million	-6,237 Reduced 47.29%	6,951 $2.74 Million
Q4 2023 Feb 13, 2024	SELL	$338.91 - $506.01 $404,319 - $603,669	-1,193 Reduced 8.3%	13,188 $5.02 Million
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $1.11 Million - $1.65 Million	-3,009 Reduced 17.3%	14,381 $7.07 Million

Q4 2022 Feb 10, 2023	BUY	$342.17 - $402.31 $207,355 - $243,799	606 Added 3.61%	17,390 $6.59 Million
Q3 2022 Nov 10, 2022	BUY	$343.2 - $395.75 $141,055 - $162,653	411 Added 2.51%	16,784 $5.93 Million
Q2 2022 Aug 11, 2022	SELL	$269.58 - $378.88 $2.83 Million - $3.98 Million	-10,500 Reduced 39.07%	16,373 $6.2 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $2.03 Million - $2.8 Million	7,984 Added 42.27%	26,873 $8.42 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $918,305 - $1.19 Million	3,376 Added 21.76%	18,889 $6.62 Million
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $316,535 - $376,172	1,073 Added 7.43%	15,513 $4.69 Million
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $274,336 - $341,354	1,067 Added 7.98%	14,440 $4.35 Million
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $282,788 - $400,846	-1,054 Reduced 7.31%	13,373 $3.68 Million
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $710,892 - $883,451	-2,865 Reduced 16.57%	14,427 $4.24 Million
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $322,402 - $407,674	1,496 Added 9.47%	17,292 $4.54 Million
Q2 2020 Aug 13, 2020	BUY	$127.44 - $232.72 $668,422 - $1.22 Million	5,245 Added 49.71%	15,796 $3.56 Million
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $3,700 - $5,617	34 Added 0.32%	10,551 $1.45 Million
Q4 2019 Feb 11, 2020	SELL	$106.59 - $164.21 $348,975 - $537,623	-3,274 Reduced 23.74%	10,517 $1.69 Million
Q3 2019 Nov 12, 2019	BUY	$113.31 - $150.51 $40,451 - $53,732	357 Added 2.66%	13,791 $1.56 Million
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $1.33 Million - $1.81 Million	13,434 New	13,434 $1.68 Million

Others Institutions Holding ARGX

# of Institutions

526

Shares Held

26M

Call Options Held

590K

Put Options Held

320K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $50.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Argenx Se Transaction History